Tg(Hes5-cre/ERT2)2Vtlr
Transgene Detail
|
|
| Symbol: |
Tg(Hes5-cre/ERT2)2Vtlr |
| Name: |
transgene insertion 2, Verdon Taylor |
| MGI ID: |
MGI:5568736 |
| Synonyms: |
Hes5::CreERT2 |
| Transgene: |
Tg(Hes5-cre/ERT2)2Vtlr Location: unknown
|
| Alliance: |
Tg(Hes5-cre/ERT2)2Vtlr page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(Hes5-cre/ERT2)2Vtlr expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Note |
| Not Specified |
Hes5 |
|
|
| |
|
Mutation details: The Hes5 promoter was used to drive the expression of cre/ERT2 when induced by tamoxifen. Four of the nine lines that were established on a C57BL/6 genetic background showed comparable CreERT2 expression in the expected Hes5 patterns.
(J:209795)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Hes5
(species not specified)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:209795 Lugert S, et al., Homeostatic neurogenesis in the adult hippocampus does not involve amplification of Ascl1(high) intermediate progenitors. Nat Commun. 2012;3:670 |
| All: |
10 reference(s) |
|
Analysis Tools
